Dalton Pharma Services Overview
- Year Founded
-
1986
- Status
-
Acquired/Merged
- Employees
-
155
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Dalton Pharma Services General Information
Description
Manufacturer of contract pharmaceutical services intended for the biotechnology and pharmaceutical industries. The company provides drug development and manufacturing services to the pharmaceutical and biotechnology industries, as well as formulation development, analytical testing, and development of various drugs.
Contact Information
Website
www.dalton.com(Operating Subsidiary)
Corporate Office
- 349 Wildcat Road
- Toronto, Ontario M3J 2S3
- Canada
Corporate Office
- 349 Wildcat Road
- Toronto, Ontario M3J 2S3
- Canada
Dalton Pharma Services Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dalton Pharma Services Comparisons
Industry
Financing
Details
Dalton Pharma Services Competitors (56)
One of Dalton Pharma Services’s 56 competitors is Symbiotec Pharmalab, a Formerly PE-Backed company based in Indore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Symbiotec Pharmalab | Formerly PE-Backed | Indore, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Siegfried Holding | Corporation | Zofingen, Switzerland | ||||
| Rottendorf Pharma | Corporation | Ennigerloh, Germany |
Dalton Pharma Services Patents
Dalton Pharma Services Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2010022520-A1 | Improved synthesis of hexahydrodibenzopyranones | Inactive | 28-Aug-2008 | ||
| WO-2010022520-A8 | Improved synthesis of hexahydrodibenzopyranones | Inactive | 28-Aug-2008 | ||
| CA-2458084-A1 | Novel process for octreotide synthesis | Inactive | 12-Mar-2004 | ||
| WO-2005087794-A1 | Process for octreotide synthesis | Inactive | 12-Mar-2004 | ||
| US-20050248483-A1 | Global positioning receiver with cross-correlation error correction | Active | 13-Aug-2002 | G01S19/21 |
Dalton Pharma Services Signals
Dalton Pharma Services Investments (1)
Dalton Pharma Services’s most recent deal was a Joint Venture with DDP Therapeutics for . The deal was made on 01-Sep-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DDP Therapeutics | 01-Sep-2005 | Joint Venture | Drug Discovery |
Dalton Pharma Services FAQs
-
When was Dalton Pharma Services founded?
Dalton Pharma Services was founded in 1986.
-
Where is Dalton Pharma Services headquartered?
Dalton Pharma Services is headquartered in Toronto, Canada.
-
What is the size of Dalton Pharma Services?
Dalton Pharma Services has 155 total employees.
-
What industry is Dalton Pharma Services in?
Dalton Pharma Services’s primary industry is Drug Discovery.
-
Is Dalton Pharma Services a private or public company?
Dalton Pharma Services is a Private company.
-
What is the current valuation of Dalton Pharma Services?
The current valuation of Dalton Pharma Services is .
-
What is Dalton Pharma Services’s current revenue?
The current revenue for Dalton Pharma Services is .
-
Who are Dalton Pharma Services’s competitors?
Symbiotec Pharmalab, Novartis, Cipla, Siegfried Holding, and Rottendorf Pharma are some of the 56 competitors of Dalton Pharma Services.
-
When was Dalton Pharma Services acquired?
Dalton Pharma Services was acquired on 28-Feb-2020.
-
Who acquired Dalton Pharma Services?
Dalton Pharma Services was acquired by Seikagaku.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process